Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 15 of 15 entries
View as:

AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT03182686 Org: User:
Start: 06/19/17 End: 12/07/17 Due: 12/07/18

Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation

Phase: N/A Priority: Normal
NCT ID: NCT04456452 Org: User:
Start: 07/27/20 End: 11/30/20 Due: 11/30/21

A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee

Phase: N/A Priority: Normal
NCT ID: NCT02024529 Org: User:
Start: 01/31/14 End: 07/31/14 Due: 07/31/15

Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen

Phase: N/A Priority: Normal
NCT ID: NCT04839965 Org: User:
Start: 07/05/21 End: 04/04/22 Due: 04/04/23

Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress

Phase: N/A Priority: Normal
NCT ID: NCT04606784 Org: User:
Start: 10/28/20 End: 06/15/21 Due: 06/15/22

A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02556710 Org: User:
Start: 09/30/15 End: 06/30/16 Due: 06/30/17

AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb Joint

Phase: N/A Priority: Normal
NCT ID: NCT02762760 Org: User:
Start: 05/31/16 End: 11/30/16 Due: 11/30/17

A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04868890 Org: User:
Start: 06/22/21 End: 04/13/22 Due: 04/13/23

A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.

Phase: N/A Priority: Normal
NCT ID: NCT01821677 Org: User:
Start: 02/26/13 End: 01/23/15 Due: 01/23/16

An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT01839331 Org: User:
Start: 03/29/13 End: 10/31/13 Due: 10/31/14

Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.

Phase: N/A Priority: Normal
NCT ID: NCT03988023 Org: User:
Start: 06/24/19 End: 07/13/21 Due: 07/13/22

A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)

Phase: N/A Priority: Normal
NCT ID: NCT04880161 Org: User:
Start: 07/26/21 End: 02/21/22 Due: 02/21/23

A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis Pain

Phase: N/A Priority: Normal
NCT ID: NCT02184156 Org: User:
Start: 06/30/14 End: 10/31/15 Due: 10/31/16

A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02242435 Org: User:
Start: 09/30/14 End: 05/31/15 Due: 05/31/16

Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT03349645 Org: User:
Start: 12/08/17 End: 10/04/18 Due: 10/04/19